MTMR6 polyclonal (N-term), anti-human
€0.00
In stock
SKU
AC-AP16543A
Catalog Number: AC-AP16543A
Size: 80 µl, 400 µl
Isotype: Rabbit IgG
Clone Name: RB36077
Applications: WB
Datasheet
Request Information
Size: 80 µl, 400 µl
Isotype: Rabbit IgG
Clone Name: RB36077
Applications: WB
Datasheet
Request Information
Background:
Phosphatase that acts on lipids with a phosphoinositol headgroup. Acts as a negative regulator of KCNN4/KCa3.1 channel activity in CD4+ T-cells possibly by decreasing intracellular levels of phosphatidylinositol-3 phosphatase. Negatively regulates proliferation of reactivated CD4+ T-cells.
Other Names:
Myotubularin-related protein 6, 313-, MTMR6
Target/Specificity:
This MTMR6 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 114-143 amino acids from the N-terminal region of human MTMR6.
Antigen Region:
114-143
Antigen Type: Synthetic Peptide
Gene Name: MTMR6 (HGNC:7453)
Gene ID: 9107
Primary Accession: Q9Y217
NCBI Accession: NP_004676.3
Other Accession: NP_004676.3
Format: Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
Phosphatase that acts on lipids with a phosphoinositol headgroup. Acts as a negative regulator of KCNN4/KCa3.1 channel activity in CD4+ T-cells possibly by decreasing intracellular levels of phosphatidylinositol-3 phosphatase. Negatively regulates proliferation of reactivated CD4+ T-cells.
Other Names:
Myotubularin-related protein 6, 313-, MTMR6
Target/Specificity:
This MTMR6 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 114-143 amino acids from the N-terminal region of human MTMR6.
Antigen Region:
114-143
Antigen Type: Synthetic Peptide
Gene Name: MTMR6 (HGNC:7453)
Gene ID: 9107
Primary Accession: Q9Y217
NCBI Accession: NP_004676.3
Other Accession: NP_004676.3
Format: Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
| Is Featured? | No |
|---|
Write Your Own Review